Julian S. Gangolli, Director at Krystal Biotech, Inc. (KRYS), sold 40,000 shares at $163.71 ($6.6M) on 2024-05-20, disclosed to the SEC on 2024-05-22.
Open-market sale of $6.6M KRYS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $163.71 | 10,930 | $1.8M | 27.3% |
| 2 | $163.71 | 10,930 | $1.8M | 27.3% |
| 3 | $164.34 | 7,090 | $1.2M | 17.7% |
| 4 | $164.34 | 7,090 | $1.2M | 17.7% |
| 5 | $165.76 | 1,980 | $328K | 5.0% |
| 6 | $165.76 | 1,980 |
| $328K |
| 5.0% |
| Total | $164.14 avg | 40,000 | $6.6M | 100% |
| Filing → |
| AGN | SELL | 2013-12-30 | $5.8M | — | Filing → |
| AGN | SELL | 2012-11-29 | $8.3M | — | Filing → |